These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12628072)

  • 1. Stress-related Mucosal Disease.
    Spirt MJ
    Curr Treat Options Gastroenterol; 2003 Apr; 6(2):135-145. PubMed ID: 12628072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-related mucosal disease: risk factors and prophylactic therapy.
    Spirt MJ
    Clin Ther; 2004 Feb; 26(2):197-213. PubMed ID: 15038943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitors for stress ulcer prophylaxis in critically ill patients.
    Jung R; MacLaren R
    Ann Pharmacother; 2002 Dec; 36(12):1929-37. PubMed ID: 12452757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-induced ulcer bleeding in critically ill patients.
    Ali T; Harty RF
    Gastroenterol Clin North Am; 2009 Jun; 38(2):245-65. PubMed ID: 19446257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress ulcer bleeding.
    Harty RF; Ancha HB
    Curr Treat Options Gastroenterol; 2006 Apr; 9(2):157-66. PubMed ID: 16539876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis.
    Pongprasobchai S; Kridkratoke S; Nopmaneejumruslers C
    J Med Assoc Thai; 2009 May; 92(5):632-7. PubMed ID: 19459523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of stress-related mucosal disease.
    Monnig AA; Prittie JE
    J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):484-95. PubMed ID: 22316196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit.
    Steinberg KP
    Crit Care Med; 2002 Jun; 30(6 Suppl):S362-4. PubMed ID: 12072662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing the gastrointestinal consequences of stress-related mucosal disease.
    Metz DC
    Curr Med Res Opin; 2005 Jan; 21(1):11-8. PubMed ID: 15881471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-related mucosal disease in the intensive care unit: an update on prophylaxis.
    Sesler JM
    AACN Adv Crit Care; 2007; 18(2):119-26; quiz 127-8. PubMed ID: 17473539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.
    Brett S
    Crit Care; 2005 Feb; 9(1):45-50. PubMed ID: 15693983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Pantoprazole on Systemic and Gastric Pro- and Anti-inflammatory Cytokines in Critically Ill Patients.
    Tabeefar H; Beigmohammadi MT; Javadi MR; Abdollahi M; Mahmoodpoor A; Ahmadi A; Honarmand H; Najafi A; Mojtahedzadeh M
    Iran J Pharm Res; 2012; 11(4):1051-8. PubMed ID: 24250536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Histamine
    Hammond DA; Kathe N; Shah A; Martin BC
    Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of pharmacologic agents for acid suppression in critically ill patients.
    Welage LS
    Am J Health Syst Pharm; 2005 May; 62(10 Suppl 2):S4-S10. PubMed ID: 15905600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
    Avendaño-Reyes JM; Jaramillo-Ramírez H
    Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of the upper gastrointestinal tract in the critically ill patient: rationale for the therapeutic benefits of acid suppression.
    Fennerty MB
    Crit Care Med; 2002 Jun; 30(6 Suppl):S351-5. PubMed ID: 12072660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors vs. histamine 2 receptor antagonists for stress-related mucosal bleeding prophylaxis in critically ill patients: a meta-analysis.
    Barkun AN; Bardou M; Pham CQ; Martel M
    Am J Gastroenterol; 2012 Apr; 107(4):507-20; quiz 521. PubMed ID: 22290403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of stress ulcers in critically ill patients.
    Yang YX; Lewis JD
    Semin Gastrointest Dis; 2003 Jan; 14(1):11-9. PubMed ID: 12610850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.